Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Neal

Showing results (241-250 of 484) with videos related to

Pageof 49
Sort By:
Endocrinology, Diabetes & Metabolism|July 19, 2021
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS ProgramKatherine M Wang, JingWei Li, Vivek Bhalla, et al.
Journal of the American College of Cardiology|October 30, 2020
Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk ReductionJames L Januzzi, Jialin Xu, JingWei Li, et al.
Journal of Human Hypertension|March 6, 2021
The impact of baseline potassium intake on the dose-response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trialsLiping Huang, Bruce Neal, Jason H Y Wu, et al.
European Heart Journal|August 23, 2023
Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortalityShishir Rao, Milad Nazarzadeh, Dexter Canoy, et al.
BMJ Open|January 21, 2014
Salt intake assessed by 24 h urinary sodium excretion in a random and opportunistic sample in AustraliaMary-Anne Land, Jacqui Webster, Anthea Christoforou, et al.
American Journal of Nephrology|January 11, 2022
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS TrialDavid Lam, Girish N Nadkarni, Gohar Mosoyan, et al.
International Journal of Epidemiology|June 5, 2003
Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: the Electricity Generating Authority of Thailand StudyPiyamitr Sritara, Sayan Cheepudomwit, Neil Chapman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 26, 2020
Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trialSudhir Raj Thout, Jie Yu, Maoyi Tian, et al.
Journal of Hypertension|December 1, 2018
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trialsAbdul Salam, Emily Atkins, Johan Sundström, et al.
Circulation|November 3, 2025
Risks of Hyperkalemia With Potassium-Enriched Salt Substitute Among Patients Using Concomitant Blockade of the Renin-Angiotensin-Aldosterone System in the Salt Substitute and Stroke StudyXuejun Yin, Liping Huang, Maoyi Tian, et al.
Pageof 49

Showing results (241-250 of 484) with videos related to

Sort By:
Pageof 49
Endocrinology, Diabetes & Metabolism|July 19, 2021
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS ProgramKatherine M Wang, JingWei Li, Vivek Bhalla, et al.
Journal of the American College of Cardiology|October 30, 2020
Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk ReductionJames L Januzzi, Jialin Xu, JingWei Li, et al.
Journal of Human Hypertension|March 6, 2021
The impact of baseline potassium intake on the dose-response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trialsLiping Huang, Bruce Neal, Jason H Y Wu, et al.
European Heart Journal|August 23, 2023
Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortalityShishir Rao, Milad Nazarzadeh, Dexter Canoy, et al.
BMJ Open|January 21, 2014
Salt intake assessed by 24 h urinary sodium excretion in a random and opportunistic sample in AustraliaMary-Anne Land, Jacqui Webster, Anthea Christoforou, et al.
American Journal of Nephrology|January 11, 2022
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS TrialDavid Lam, Girish N Nadkarni, Gohar Mosoyan, et al.
International Journal of Epidemiology|June 5, 2003
Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: the Electricity Generating Authority of Thailand StudyPiyamitr Sritara, Sayan Cheepudomwit, Neil Chapman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 26, 2020
Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trialSudhir Raj Thout, Jie Yu, Maoyi Tian, et al.
Journal of Hypertension|December 1, 2018
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trialsAbdul Salam, Emily Atkins, Johan Sundström, et al.
Circulation|November 3, 2025
Risks of Hyperkalemia With Potassium-Enriched Salt Substitute Among Patients Using Concomitant Blockade of the Renin-Angiotensin-Aldosterone System in the Salt Substitute and Stroke StudyXuejun Yin, Liping Huang, Maoyi Tian, et al.
Pageof 49